Onyx Healthcare Inc (6569) Fair Value & Analysis
Healthcare · TW · Market cap 3.9B TWD
Fair value as of: Jul 21, 2026
From 22 valuation models · updated 20 days ago
Share price −10.8% over the past month.
A solid business, but screening 54% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (51.82 TWD). The favourable scenario is already priced in.
- Solid but not exceptional quality (64/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 21, 2026.
How to read this chart
60‑month range 67.28 TWD – 215.63 TWD · fair‑value band 36.59 TWD – 51.82 TWD · the 95.00 TWD price screens above the 43.29 TWD fair value. Dashed = 300-day average. As of Jul 21, 2026.
Analysis
Onyx Healthcare Inc (6569) currently trades at 95.00 TWD, while our model-based Fair Value estimate is 43.29 TWD, implying the stock looks roughly 54.4% overvalued today. The Quality Score stands at 64/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Onyx Healthcare Inc generated revenue of 1.4B TWD at a net margin of 10.5%. Revenue grew 21.8% year over year. It earns a return on equity of 9.0%. The balance sheet holds a net cash position of 160M TWD. Fundamentals as of Jul 21, 2026
Our scenario range runs from 36.59 TWD (bear case) to 51.82 TWD (bull case); at 95.00 TWD, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 40% below its 52-week high and 3% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -53% fair-value upside, at -54%, 6569 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 22 models by family
Widest divergence: Growth Earnings (47.69 TWD) versus Earnings-Based (13.46 TWD). Highest evidence: Growth DCF (80).
Notify me when 6569 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 21, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 64 · Market factors (momentum, volatility) 40
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Onyx Healthcare Inc., a professional medical IT company, engages in the design, manufacture, and trade of medical computers and peripherals for hospital/clinical IT market in Taiwan, the United States, and internationally. The company offers medical AI computer; medical tablet, power bank, and display; and medical panel and box PC.
Full company description
Onyx Healthcare Inc., a professional medical IT company, engages in the design, manufacture, and trade of medical computers and peripherals for hospital/clinical IT market in Taiwan, the United States, and internationally. The company offers medical AI computer; medical tablet, power bank, and display; and medical panel and box PC. It also provides ODM/OEM services; smart view medical stations; fan less slim panel PC; medical display; healthcare infotainment; and medical pc and mobile computing cart. The company was incorporated in 2010 and is based in New Taipei City, Taiwan.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Onyx Healthcare Inc reported revenue of 1.3B TWD in FY2025 versus 1.2B TWD in FY2021, a compound +2.2%/yr. Reported net income was 112M TWD in FY2025, compounding −3.2%/yr from FY2021.
6569 screens 54% overvalued. Compare with Veeva Systems Inc →
Peer Group
Health Information Services · 126 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Health Information Services median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veeva Systems Inc VEEV | $190.12 | $95.12 | -50% |
| Pro Medicus Limited PME | A$194.84 | A$23.74 | -88% |
| BrightSpring Health Services, Inc BTSG | $68.16 | $21.31 | -69% |
| HealthEquity, Inc HQY | $97.67 | $56.63 | -42% |
| Hinge Health, Inc HNGE | $88.80 | $24.03 | -73% |
| 10x Genomics, Inc TXG | $45.75 | $17.18 | -62% |
| Waystar Holding WAY | $22.69 | $12.86 | -43% |
| Doximity, Inc DOCS | $22.21 | $17.18 | -23% |
| Privia Health Group PRVA | $28.10 | $5.30 | -81% |
| Inventurus Knowledge Solutions Limited IKS | ₹1,846 | ₹860.28 | -53% |
Compare Onyx Healthcare Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Onyx Healthcare Inc (6569) overvalued or undervalued?
What is the fair value of 6569?
What is the quality score of 6569?
What is the revenue of Onyx Healthcare Inc (6569)?
What is the net profit margin of 6569?
Does Onyx Healthcare Inc pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Onyx Healthcare Inc and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.